Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Intel Stock Looks Like It’s Worth Your Dollars

By Alex Sirois, InvestorPlace Contributor
INTC stock got pummeled in 2020, but 2021 is looking like a great time to make a bet on Intel while its cheap. Read why here.

Why Everyone Loving Xpeng Stock Is Also the Reason for Caution

By Josh Enomoto, InvestorPlace Contributor
While Xpeng stock is off to a brilliant start in 2021, investors should consider the longer-term challenges of EVs before making a serious wager.

After a Successful Nio Day, Shares in NIO Still Look Pricey 

By Vandita Jadeja
After a successful NIO Day and exciting announcements, NIO stock has soared to life-time highs. However, it looks overvalued.

Don’t Write Off the ContextLogic-Wish IPO As a Flop

By David Moadel, InvestorPlace Contributor
While not necessariliy off to a great start like some other IPO's, WISH stock could be an outstanding e-commerce play in 2021.

Here’s Why Carnival Might Suffer 3 Years of Soft Data

By Josh Enomoto, InvestorPlace Contributor
On the surface, CCL stock appears a compelling contrarian play on the reality that pandemics don’t last forever. At the same time, speculators should anticipate years of softness before a full recovery takes place.

OGEN Stock Alert: Why Oragenics Shares Are Flying Again Thursday

By William White, InvestorPlace Writer
Oragenics (OGEN) stock is soaring higher on Thursday from new coronavirus vaccine news after just receiving a boost last week.

Bakkt: ICE Crypto Exchange Going Public

By Dana Blankenhorn, InvestorPlace Contributor
Bakkt is based on an app that will take various forms of payment, like Starbucks' points, and turn them into spendable cash.

SRAC Stock: 10 Things to Know About Stable Road Acquisition SPAC and Space Tow Company Momentus

By William White, InvestorPlace Writer
Stable Road Acquisition (SRAC) a SPAC planning to merge with Momentus is seeing shares of its stock soar higher on Thursday.

Google Stock Is Likely to Suffer Under Political Pressure

By Dana Blankenhorn, InvestorPlace Contributor
Google faces various political challenges to its growth from around the world. Will Google stock survive the storm?

4 Marijuana Penny Stocks Winning Under Democratic Leadership

By Ian Cooper, InvestorPlace Contributor
While cannabis legalization may not be a slam-dunk, that hasn’t stopped investors from sending marijuana penny stocks to higher highs.

Ideanomics Hangs Its Hope on the Underlying Conversion Potential

By Josh Enomoto, InvestorPlace Contributor
IDEX stock is backed by some intriguing concepts in the electric vehicle space, but its implied practicality is a question mark.

Palantir Technologies Is Still in Wait-and-See Mode

By Lou Carlozo, InvestorPlace Contributor
Palantir stock may belong to a robust sector of huge tech investments. But it still needs to prove that it's worth the risk.

Expect This Pullback in High-Flying Zomedica Pharmaceuticals Stock to Continue

By David Moadel, InvestorPlace Contributor
Even with the company addressing a potentially hyper-growth market, the price action of ZOM stock is just too frothy.

Xpeng Presents Many Questions, But Few Clear Answers

By Chris Markoch, InvestorPlace Contributor
Xpeng stock is down nearly 30% since late November. In the midst of an EV bubble, what drove the tumble in XPEV stock?

Nikola’s Altered Agreement with GM Permanently Changed the Equation

By Will Ashworth, InvestorPlace Contributor
Nikola’s revised agreement with General Motors sent owners of NKLA stock scurrying for the exits. Is there any upside left?

Step Cautiously in Ideanomics Stock

By Mark R. Hake, CFA
Expect to see a huge push in IDEX stock so it can afford all its purchases. Ideanomics will likely need to raise at least $60 million, which could cause 16% dilution or more.

One Percenter: “I Wish Everybody Knew This, So They Could Be Rich”

By InvestorPlace Staff
One of America’s richest men is stepping forward with an important message to all Americans.

Power Portfolio 2021: Why We’re Closing Our Portfolio

By InvestorPlace Research Staff
Louis Navellier and Matt McCall are in complete agreement that the coming year has all the makings of a big year in the market … and an even bigger year for the stocks they’ve picked together.

Novavax Will Likely Do Well Once Its Covid-19 Vaccine Trials Come Out

By Mark R. Hake, CFA
NVAX stock is poised for returns once its Phase 3 trial results come out, but potential investors should keep their eyes on the news.
Load More Articles